


Healthcare News Roundup: Neuro
HSMN NewsFeed - 18 Sep 2018
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
HSMN NewsFeed - 11 Sep 2018
Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
HSMN NewsFeed - 5 Sep 2018
NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX(R) 20 Degree Implant
NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX(R) 20 Degree Implant
HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
HSMN NewsFeed - 23 Aug 2018
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 22 Aug 2018
MagVenture, Inc: FDA Clears 3-Minute, Non-Pharmaceutical Depression Treatment
MagVenture, Inc: FDA Clears 3-Minute, Non-Pharmaceutical Depression Treatment
HSMN NewsFeed - 17 Aug 2018
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
HSMN NewsFeed - 3 Aug 2018
Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and Syed Jafry to Board of Directors
Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and Syed Jafry to Board of Directors
HSMN NewsFeed - 2 Aug 2018
Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
